Fluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsA practical algorithm for managing Alzheimer's disease: what, when, and why?Drug development in Alzheimer's disease: the path to 2025Dysprosodic speech following basal ganglia insult: toward a conceptual framework for the study of the cerebral representation of prosodyEffect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyThe advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.Performance of a shortened Scale for Assessment of Positive Symptoms for Parkinson's disease psychosis.Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.Strategies for analysing behavioural data in clinical trials involving patients with Alzheimer's disease.Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive DimensionsProgressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology.The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.Disease-modifying therapies for Alzheimer disease: challenges to early intervention.Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease.Persistence of neuropsychological testing deficits in mild cognitive impairment.Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis.Treatment of Depression in the Patient with Parkinson's Disease.Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes.Association of GSK3B with Alzheimer disease and frontotemporal dementiaEffects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severitySurface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly.Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's diseaseAutomated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects.Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative.Controversies in Alzheimer's disease drug developmentThe "Alzheimer's type" profile of semantic clustering in amnestic mild cognitive impairmentApathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type.Alzheimer's disease drug-development pipeline: few candidates, frequent failuresCurrent concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease.Integrating ADNI results into Alzheimer's disease drug development programs.Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's diseaseProvisional diagnostic criteria for depression of Alzheimer disease.Guidelines for managing Alzheimer's disease: part I. Assessment.Guidelines for managing Alzheimer's disease: Part II. Treatment.Subtle deficits in instrumental activities of daily living in subtypes of mild cognitive impairment
P50
Q26784569-46F839D0-497C-4B4C-8CA5-8EB0CBEA044DQ26859831-6B5E3B3C-D2BA-4EE4-BEBB-D49BE6B927B7Q27007748-9CF666F7-B144-430A-B291-9DD3B7738507Q28280466-EF3845BB-0C16-43A6-99CF-0ECE0120E83DQ28302829-6B8CDA39-DE41-4261-A24B-AE6C70CE85AAQ28485924-B7419388-B6CF-4F8B-A9ED-3FB4EA6B30B6Q28943325-CC3F0659-716C-4B8F-A4A7-D316385EE429Q30434949-12CA100E-699A-4391-8016-6BF0DEDA6565Q30456301-4C443B77-A159-41E7-96E0-9E6B393C641BQ30458193-78961D19-EFF1-4FD2-9B72-4C837F947234Q30496583-2BEC2A59-0899-4D1A-98BA-4E06DAA09B9BQ30643766-256AB25B-C463-4244-B621-B9A50A5B9129Q30998279-62874A1A-CF68-4758-950C-10B1B0854D29Q30998627-0E3B5A24-1A0D-4E83-83DE-BA3EC424F109Q31081008-AEE7E585-FBA6-4754-BB53-D03BBAB20A34Q31133189-5EEBC7FA-5AA3-4E8C-BA79-F32B9EC185FAQ33319083-288A3FF6-FE4D-430A-BB77-A38ED7082973Q33454243-33F68925-14E1-4675-A113-5011F1954089Q33599473-9C2058F9-8414-4156-B186-1EF9EA0D41CAQ33621777-BE3E58D8-F1E3-4E26-9A5F-FEDC44BE7E63Q33633733-8BDFC677-3FA7-4F91-AEE5-AB31952EBFDCQ33704127-976DEC29-33E0-42CF-9216-8CA9BA631AB0Q33736797-854F96E4-0800-4F3D-AC86-249732BD165AQ33737139-41E6F8F4-85F5-42FB-91CA-9AAFC5C71623Q33746082-9A2B789B-F8B4-4C5D-A49E-ADA3AB612153Q33749553-CDB011D6-F272-45C8-AACB-AA66EA454E1EQ33756869-F0AA6028-7BC9-44AD-AD99-61077335F2D3Q33759397-4EFC8431-9254-4668-992E-71E1D834373DQ33794509-C101E374-6C71-4F52-BCE4-33B95245F84DQ33805090-D342CA7E-6688-471A-9B41-2951BFA904FBQ33864076-6D96BC64-5FB4-4151-8556-AAEEDCAAA634Q33874226-583B6193-7527-4AB1-84B2-C761B969E18DQ33892815-1FFA8D9D-7B67-491C-BB07-B4B95F49FA8DQ33921483-1BE8A64E-48BA-4346-B747-6F75D1612FBBQ33987409-14A4FB4F-DBF7-492B-91FD-40A2CAE3FBB5Q34076179-002F83D7-3B4B-4827-AF70-C01E3FED0392Q34121328-EEE7A948-2DA0-445D-8A6E-DB21B1D1D1CAQ34134222-3012F590-38AD-47D6-A05B-F0D07ACD2502Q34135609-1D90DF5C-F7A9-43F6-B255-B6FAA28C6E68Q34168819-559487DC-E4C5-47AB-A283-53C3C28170C1
P50
description
American neurologist
@en
neurolojiste american
@lfn
neuroloog
@nl
neurólogo estadounidense
@es
usona neŭrologo
@eo
name
Jeffrey Cummings
@ast
Jeffrey Cummings
@de
Jeffrey Cummings
@es
Jeffrey Cummings
@nl
Jeffrey L. Cummings
@en
Jeffrey L. Cummings
@pt
type
label
Jeffrey Cummings
@ast
Jeffrey Cummings
@de
Jeffrey Cummings
@es
Jeffrey Cummings
@nl
Jeffrey L. Cummings
@en
Jeffrey L. Cummings
@pt
altLabel
Jeffrey Cummings
@en
Jeffrey L. Cummings
@ast
Jeffrey L. Cummings
@nl
prefLabel
Jeffrey Cummings
@ast
Jeffrey Cummings
@de
Jeffrey Cummings
@es
Jeffrey Cummings
@nl
Jeffrey L. Cummings
@en
Jeffrey L. Cummings
@pt
P1006
P214
P244
P1006
P106
P1153
7402590824
P1580
P166
P21
P214
P244
P31
P496
0000-0001-8944-4158
P569
1948-03-08T00:00:00Z
1948-08-03T00:00:00Z
P691
nlk20020117552
P734
P735
P7859
lccn-n83063229